this QR result underperformed.. i think have to wait at least for another 6 months.. bad luck bought in this garbage..😥 mgt trustwortiness put into questionmark, where was the Sept 23 sales to Stellantis Group..
Meanwhile, the automotive segment contribution is also expected to deliver improvement from supply of wire harnesses and fuel tanks for the Peugeot 5008, 3008 and 2008 models to Stellantis with deliveries expected from September 2023 onwards.
Pp said you mention too many fake news, one day pp will realise and not going to believe you anymore. This is what scomnet mgt gives impression to public..
It’s getting attractive… silly to run… it’s time to collect…
Stellantis is evaluating Gurun’s potential to be a regional hub for battery-electric vehicles (BEVs) for domestic and export markets. In essence, analyst believe the expansion of Stellantis in ASEAN (via Gurun, Kedah) will bode well for Scomnet.
In addition, Scomnet has been approached by a European automotive player to produce wire harness for Chrysler models in the US market.
Automotive to Fully Recover by 2Q24 Management shared that 4Q23 automotive contribution would remain flat QoQ but full recovery is expected to happen by either 1Q24 or 2Q24. We understand that Scomnet’s customer, Stellantis is evaluating Gurun’s potential to be a regional hub for battery-electric vehicles (BEVs) for domestic and export markets. In essence, we believe the expansion of Stellantis in ASEAN (via Gurun, Kedah) will bode well for Scomnet.
In addition, Scomnet has been approached by a European automotive player to produce wire harness for Chrysler models in the US market. If successful, the first project is expected to begin in March or April 2024 and contribute around RM10-15mn sales per annum.
Medical Segment Sets to Grow Further Moving into 4Q23, the group is confident that the medical segment contribution will increase by 15-20% QoQ driven by higher sales to Edward (40% of 3Q23 revenue) and recovery in orders from Ambu (29% of 3Q23 revenue). We note that Supercomnet has been chosen by Edwards Lifesciences (market cap of above USD50bn) as the best quality supplier (more than 700 suppliers) and achieved gold status in 2023. Edward will be using more digital smart cable (from analog cable) for its products such as its inbuilt PCB Board somewhere in the middle of 2024. For Ambu, the growth will come from endoscopes, gastroscopes and colonoscope (US FDA approved in Sep-23).
Price is rather high (PE 34x) while future upside is not that great.. Mermaid orders would be halted in April this year. Though it’s mentioned to be resumed by Sept when internal dispute is settled, there is uncertainty whether the dispute can be settled by then..
better wait for it the price to be cheaper first then only enter..
Be cautious of this company. Between August 2020 and March 2024, they have continually added 170,117,400 shares through additional listings, which dilutes shareholder benefits. This trend of adding approximately 3,956,218 shares per month continues.
The management of this listed company is not sincere in fostering business growth; instead, they manipulate share units for their own benefit.
c328 , the Company issued FREE warrant of 1:3 to all existing shareholders on 2019, then they are eligible to convert warrant at RM0.65 per share (which the price are similar at the mother share price at 2019). So the convertion is a REWARD to shareholders who hold long term.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
MrFox
1,362 posts
Posted by MrFox > 2023-11-24 17:09 | Report Abuse
fruitcake becomes mouldy?